Skip to main content
European Health and Digital Executive Agency (HaDEA)
  • Call for proposals
  • Open

Development of antibodies and antibody-derived proteins for the prevention and treatment of infectious diseases with epidemic potential

Details

Status
Open
Reference
HORIZON-HLTH-2025-01-DISEASE-03
Publication date
Opening date
Deadline model
Single-stage
Deadline date
16 September 2025, 17:00 (CEST)
Programme Sector
  • Health
Programme
  • Horizon Europe
  • Horizon Europe Cluster 1: Health

Description

Proposal under the topic HORIZON-HLTH-2025-01-DISEASE-03 should aim to deliver results that are directed, tailored towards and contributing to all the following expected outcomes:

  • The scientific and clinical communities have a better understanding of prophylactic and treatment options complementary to low molecular weight antiviral therapeutics for viruses with epidemic potential.
  • The scientific and clinical communities have access to experimental antibodies and antibody-derived proteins for the prevention and treatment of emerging or re-emerging viral infections, as well as for further clinical investigation.
  • Candidate antiviral therapies, including potentially those of broad spectrum are available for emerging and re-emerging viral infections, increasing therapeutic options for clinical deployment in case of an epidemic or pandemic.

Interested parties can find more information and apply on the Funding and Tenders Portal.